Events

Upcoming Events

No events to display.

Past Events

39th Annual J.P. Morgan Healthcare Conference
// 39th Annual J.P. Morgan Healthcare Conference

LAVA Therapeutics Presents a Corporate Overview at 39th Annual J.P. Morgan Healthcare Conference.

Antibody Engineering and Therapeutics Conference
// Antibody Engineering and Therapeutics Conference

Want to learn more about how engaging T-cells via bispecific antibodies can change the course of cancer treatment? LAVA’s EVP, Head of R&D Paul Parren, PhD is chairing the ‘Bispecific T cell Engagers’ session at the Antibody Engineering and Therapeutics conference on Monday, December 14. LAVA’s CSO, and Hans van der Vliet, MD, PhD, will be on the panel. More information.

// 12th Annual PEGS Europe Conference

Lava’s EVP and Head of R&D, Paul Parren, PhD, and CSO, Hans van der Vliet, MD, PhD, will speak at the 12th Annual PEGS Europe Conference on Nov 11.

9am – Paul Parren – Next-Generation T Cell Engagers
9:20am – Hans van derVliet – Bispecific γδ-T Cell Engagers for Cancer Immunotherapy.
11:55am – Paul Parren – Panel Discussion: Gamma Delta T Cell Therapy

// SABCS – 2020 San Antonio Breast Cancer Symposium

Lava’s EVP and Head of R&D, Paul Parren, PhD, spoke about the use of antibody drug conjugates in BCa. Learn more about the power of antibodies here

// 8th Antibody Industrial Symposium (AIS) Congress

Lava’s EVP and Head of R&D, Paul Parren, PhD, will give an opening keynote address at the 8th Antibody Industrial Symposium (AIS) Congress on November 23rd at 9am CET. More information about this event

// European Antibody Congress 2020

Lava’s EVP and Head of R&D, Paul Parren, PhD, will speak at the European Antibody Congress 2020. More information about this event.